512
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes

&
Pages 209-221 | Published online: 04 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maria Ida Maiorino, Michela Petrizzo, Annalisa Capuano, Dario Giugliano & Katherine Esposito. (2014) The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?. Expert Opinion on Biological Therapy 14:6, pages 799-808.
Read now
Katherine Esposito, Annalisa Capuano & Dario Giugliano. (2012) Humalog (lispro) for type 2 diabetes. Expert Opinion on Biological Therapy 12:11, pages 1541-1550.
Read now

Articles from other publishers (4)

Florence M. Brunel, Fa Liu & John P. Mayer. 2019. Successful Drug Discovery. Successful Drug Discovery 1 33 .
Araceli Muñoz-Garach, María Molina-Vega & Francisco J. Tinahones. (2016) How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes. Diabetes Therapy 8:1, pages 9-22.
Crossref
George Dailey & Edward Wang. (2014) A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes. Diabetes Therapy 5:2, pages 385-402.
Crossref
Anastasia N. Mavrogiannaki & Ilias N. Migdalis. (2012) Long-acting basal insulin analogs: latest developments and clinical usefulness. Therapeutic Advances in Chronic Disease 3:6, pages 249-257.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.